Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Case Report

Castleman Disease of the Kidney in Computed Tomography Urography

Author(s): Kai Wang, Fengjuan Xing, Heng Ma and Wenjuan Li*

Volume 18, Issue 1, 2022

Published on: 01 June, 2021

Article ID: e010621193750 Pages: 4

DOI: 10.2174/1573405617666210601153220

Price: $65

Abstract

Background: Castleman Disease (CD) of the kidney is extremely rare. In this study, we have presented a case of CD of the left kidney and comprehensively described the findings of computed tomography urography.

Case Presentation: The case involved unusual imaging characteristics of the focal central cystic area.

Conclusion: The small and regular cyst-like structures and the hyperdense mass relative to the renal parenchyma in plain scans might help distinguish the CD of the kidney from other hypervascular tumors.

Keywords: Giant lymph node hyperplasia, kidney, kidney cortex tomography, X-Ray computed, urography, lesion.

Graphical Abstract
[1]
Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood 2020; 135(16): 1353-64.
[http://dx.doi.org/10.1182/blood.2019000931] [PMID: 32106302]
[2]
Hatano K, Fujita S, Tsujimoto Y, et al. Rare case of the hyaline vascular type of Castleman’s disease of the kidney. Int J Urol 2007; 14(12): 1098-100.
[http://dx.doi.org/10.1111/j.1442-2042.2007.01900.x] [PMID: 18036051]
[3]
Mah NA, Peretsman SJ, Teigland CM, Banks PM. Castleman disease of the hyaline-vascular type confined to the kidney. Am J Clin Pathol 2007; 127(3): 465-8.
[http://dx.doi.org/10.1309/51U9EWBTPQAM61TT] [PMID: 17276946]
[4]
Hoshi A, Nitta M, Tokunaga M, et al. Castleman’s disease in the pararenal retroperitoneal space, which is indistinguishable from renal cell carcinoma: A case report. Hinyokika Kiyo 2007; 53(1): 43-8.
[PMID: 17310768]
[5]
Kwon JH, Min SK, Shin MK, Lee YS, Lee YG, Ko YH. Hyaline vascular castleman disease involving renal parenchyma and a lymph node: A case report. Korean J Pathol 2012; 46(1): 79-82.
[http://dx.doi.org/10.4132/KoreanJPathol.2012.46.1.79] [PMID: 23109983]
[6]
Ooi CC, Cheah FK, Wong SK. Castleman’s disease of the kidney: Sonographic findings. J Clin Ultrasound 2015; 43(7): 438-42.
[http://dx.doi.org/10.1002/jcu.22192] [PMID: 24947075]
[7]
Wang Y, Dong A, Yang B, Lu J. Castleman’s disease of the kidney mimicking renal cell carcinoma on FDG PET/CT. Clin Nucl Med 2018; 43(5): e160-3.
[http://dx.doi.org/10.1097/RLU.0000000000001995] [PMID: 29432340]
[8]
Li Y, Zhao H, Su B, Yang C, Li S, Fu W. Primary hyaline vascular Castleman disease of the kidney: Case report and literature review. Diagn Pathol 2019; 14(1): 94-9.
[http://dx.doi.org/10.1186/s13000-019-0870-9] [PMID: 31439011]
[9]
Cronin DM, Warnke RA. Castleman disease: An update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009; 16(4): 236-46.
[http://dx.doi.org/10.1097/PAP.0b013e3181a9d4d3] [PMID: 19546611]
[10]
Germaine LM, Newhouse JH. Castleman’s disease. Clin Imaging 2003; 27(6): 431-4.
[http://dx.doi.org/10.1016/S0899-7071(03)00022-6] [PMID: 14585575]
[11]
Casper C. The aetiology and management of Castleman disease at 50 years: Translating pathophysiology to patient care. Br J Haematol 2005; 129(1): 3-17.
[http://dx.doi.org/10.1111/j.1365-2141.2004.05311.x] [PMID: 15801951]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy